Fig. 2From: Activity of anthracycline- and ifosfamide-based chemotherapy in a series of patients affected by advanced myxofibrosarcomaSurvival functions for patients treated with continuous infusion HDIFX (28 patients). a PFS (median 4 months). b OS (median 12 months)Back to article page